EDGAR Filing Documents for 0001379434-08-000023

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001379434-08-000023

Filing Date

2008-11-20

Accepted

2008-11-20 15:53:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sch13g.htm	SC 13G	51960
	Complete submission text file	0001379434-08-000023.txt		53721

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50514 | Film No.: 081203940
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2311 CEDAR SPRINGS ROAD SUITE 100 DALLAS TX 75201

Business Address 214-468-3305

Starcher Michael D. (Filed by) CIK: 0001450334 (see all company filings)

Type: SC 13G